Description

This curriculum spans the technical and operational complexity of a multi-phase protein engineering initiative, comparable to an integrated drug discovery program combining structural bioinformatics, high-throughput variant analysis, and automated workflow deployment across academic-industrial collaboration settings.

Module 1: Foundations of Protein Structure and Function in Silico

Select and validate structural templates from the PDB based on resolution, R-free values, and biological relevance for homology modeling.
Assess functional annotation reliability in UniProt entries by cross-referencing experimental evidence codes and literature.
Implement domain boundary detection using Pfam and InterPro to guide construct design for expression and crystallization.
Diagnose and correct steric clashes and Ramachandran outliers in modeled structures using MolProbity or Rosetta.
Configure and benchmark force fields (e.g., CHARMM36, AMBER) for specific protein classes such as membrane proteins or disulfide-rich peptides.
Evaluate the impact of post-translational modification sites on structural stability using PTM-specific scoring matrices.
Integrate evolutionary conservation data from ConSurf into structural models to prioritize functional residues for mutagenesis.
Design minimal functional domains for recombinant expression by reconciling structural data with proteolytic susceptibility predictions.

Module 2: High-Throughput Sequence Analysis and Variant Prioritization

Construct custom multiple sequence alignments using HMMER and MAFFT with gap penalties tuned for specific protein families.
Filter and rank missense variants from NGS data using combined metrics: SIFT, PolyPhen-2, and CADD scores with clinical databases.
Implement parallelized BLAST+ workflows to annotate large-scale metagenomic datasets with species and function assignment.
Develop sequence entropy profiles to identify co-evolving residue pairs for allosteric site prediction.
Apply deep mutational scanning data to calibrate in silico prediction models for variant effect size.
Integrate ClinVar and gnomAD frequencies to flag variants with potential false-positive pathogenicity claims.
Build custom databases for proprietary protein families using MMseqs2 for rapid similarity searches.
Optimize k-mer size and coverage thresholds in de novo assembly of transcriptomic data for isoform detection.

Module 3: Homology Modeling and Loop Reconstruction

Select template structures based on global and local sequence identity, especially in CDR or active site regions.
Reconstruct missing loops using ab initio sampling in MODELLER or Rosetta with clustering to identify dominant conformers.
Validate loop models with MolProbity clashscores and validate hydrogen bonding patterns with HBPLUS.
Adjust dihedral restraints in MODELLER to prevent overfitting to low-quality template regions.
Assess model uncertainty using discrete optimized protein energy (DOPE) scores across multiple models.
Integrate cryo-EM density maps as restraints during loop modeling when available at intermediate resolution.
Implement iterative refinement cycles combining energy minimization and molecular dynamics relaxation.
Compare alternative loop conformations against SAXS data to assess solution-state compatibility.

Module 4: Protein-Ligand Docking and Binding Affinity Prediction

Prepare binding site grids in AutoDock Vina or Glide using conserved residue constraints from alignment data.
Validate docking poses using known co-crystallized ligands and RMSD thresholds under 2.0 Å.
Apply water displacement analysis to prioritize ligands that displace high-energy hydration sites.
Estimate binding free energies using MM/GBSA with explicit solvent equilibration steps in AMBER.
Compare consensus scoring across RF-Score, ΔVina, and empirical scoring functions to reduce false positives.
Model induced fit effects using ensemble docking with multiple receptor conformations from MD simulations.
Integrate SPR or ITC data to recalibrate scoring function weights for specific target classes.
Assess ligand strain energy post-docking to eliminate poses with unrealistic conformational penalties.

Module 5: De Novo Protein Design and Stability Optimization

Define backbone scaffolds using TOP7 or TIM-barrel frameworks based on desired symmetry and function.
Optimize core packing with RosettaDesign using dead-end elimination and Monte Carlo side-chain sampling.
Balance hydrophobicity and charge distribution in designed sequences to prevent aggregation.
Validate folding propensity using AGADIR or Zyggregator for helical content and solubility prediction.
Implement negative design to destabilize off-target folds using repulsive electrostatic potentials.
Test stability mutants via CUPSAT or FoldX before experimental validation, focusing on ΔΔG thresholds >1.5 kcal/mol.
Design disulfide bonds using MODIP with geometric criteria: Cα–Cα distance <10 Å and dihedral strain <30°.
Integrate deep learning predictions from ProteinMPNN to enhance sequence recovery rates in structural motifs.

Module 6: Molecular Dynamics Simulations for Functional Insight

Prepare solvated systems with TIP3P water and neutralizing ions at physiological ionic strength (150 mM NaCl).
Equilibrate systems using position-restrained minimization and NVT/NPT ensembles with PME electrostatics.
Configure simulation length based on system size and property of interest: >100 ns for folding, >1 µs for allostery.
Monitor convergence using RMSD, radius of gyration, and secondary structure persistence over time.
Identify metastable states using Markov state models (MSMs) built from clustered trajectory ensembles.
Analyze hydrogen bond occupancy and salt bridge lifetimes to assess active site stability.
Calculate binding free energies via thermodynamic integration (TI) with lambda window spacing <0.1.
Validate simulation outcomes against NMR order parameters or DEER spectroscopy data.

Module 7: Machine Learning Integration in Protein Engineering

Select training datasets for supervised models based on experimental throughput and measurement consistency.
Preprocess sequence embeddings using UniRep or ESM-2 representations as input features for regression tasks.
Address class imbalance in functional vs. non-functional variant datasets using SMOTE or weighted loss.
Interpret model predictions using SHAP or integrated gradients to identify influential residues.
Deploy ensemble models (XGBoost, Random Forest) to predict expression yield from sequence and codon usage.
Validate model generalizability using leave-one-family-out cross-validation in multi-target scenarios.
Implement active learning loops to iteratively select high-impact variants for experimental testing.
Monitor model drift in production by tracking prediction entropy on incoming screening data.

Module 8: Data Integration and Workflow Automation

Design modular Snakemake or Nextflow pipelines to integrate sequence, structure, and assay data processing.
Standardize data formats using HDF5 or Parquet for efficient storage of simulation trajectories and variant scores.
Implement metadata tracking with OMOP or custom schemas to ensure reproducibility across experiments.
Configure CI/CD pipelines for automated testing of bioinformatics tools using GitHub Actions and Docker.
Deploy REST APIs for model inference with rate limiting and input validation for production use.
Integrate Jupyter-based analysis templates with version-controlled notebooks using DVC.
Establish audit trails for critical decisions such as variant prioritization using ELK stack logging.
Orchestrate HPC job submissions using SLURM with dependency-aware scheduling for multi-stage workflows.

Module 9: Ethical, Regulatory, and IP Considerations in Protein Engineering

Conduct sequence homology searches against patent databases (e.g., USPTO, WIPO) to assess freedom-to-operate.
Document experimental design decisions to support patent claims for novel protein constructs.
Implement biosafety checks using BLAST against toxin and virulence factor databases (e.g., ToxProt).
Adhere to institutional biosafety level (BSL) requirements when designing gain-of-function variants.
Ensure GDPR and HIPAA compliance when handling patient-derived variant data in clinical applications.
Define data access controls for proprietary protein designs using role-based permissions in LIMS.
Report engineered sequences to INSDC with appropriate biosample and biosource metadata.
Assess dual-use potential of designed proteins using NSABB guidelines and institutional review.